loadpatents
name:-0.01295018196106
name:-0.023895025253296
name:-0.00049686431884766
Breu; Volker Patent Filings

Breu; Volker

Patent Applications and Registrations

Patent applications and USPTO patent grants for Breu; Volker.The latest application filed is for "guanidine derivatives".

Company Profile
0.20.8
  • Breu; Volker - Schliengen DE
  • Breu; Volker - D-Schliengen DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Guanidine derivatives and their use as neuropeptide FF receptor antagonists
Grant 7,727,979 - Caroff , et al. June 1, 2
2010-06-01
Guanidine derivatives
Grant 7,544,691 - Breu , et al. June 9, 2
2009-06-09
Neuropeptide Y antagonists
Grant 7,265,125 - Breu , et al. September 4, 2
2007-09-04
Guanidine derivatives
App 20070123510 - Breu; Volker ;   et al.
2007-05-31
Guanidine derivatives and their use as neuropeptide ff receptor antagonists
App 20060194788 - Caroff; Eva ;   et al.
2006-08-31
Pyrrolidone carboxamides
Grant 7,067,549 - Isler , et al. June 27, 2
2006-06-27
Pyrrolidone carboxamides
App 20050192292 - Isler, Markus ;   et al.
2005-09-01
Neuropeptide Y antagonists
App 20050176698 - Breu, Volker ;   et al.
2005-08-11
Neuropeptide Y antagonists
Grant 6,900,226 - Breu , et al. May 31, 2
2005-05-31
Naphthalenyl piperidines as renin inhibitors
Grant 6,673,931 - Breu , et al. January 6, 2
2004-01-06
Pyrimidine derivatives
Grant 6,657,060 - Breu , et al. December 2, 2
2003-12-02
Heterocyclic sulfonamides
App 20020137933 - Breu, Volker ;   et al.
2002-09-26
Heterocyclic sulfonamides
Grant 6,417,360 - Breu , et al. July 9, 2
2002-07-09
Naphthalenyl piperidines as renin inhibitors
App 20020087002 - Breu, Volker ;   et al.
2002-07-04
Pyrimidine derivatives
App 20020086858 - Breu, Volker ;   et al.
2002-07-04
Neuropeptide Y antagonists
App 20020052356 - Breu, Volker ;   et al.
2002-05-02
Naphthalenylmethoxypiperidines as renin inhibitors
Grant 6,376,672 - Breu , et al. April 23, 2
2002-04-23
Heterocyclic sulfamides
Grant 6,242,601 - Breu , et al. June 5, 2
2001-06-05
Piperidine derivatives
Grant 6,197,959 - Breu , et al. March 6, 2
2001-03-06
Piperidine derivative having renin inhibiting activity
Grant 6,150,526 - Binggeli , et al. November 21, 2
2000-11-21
Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
Grant 6,133,442 - Breu , et al. October 17, 2
2000-10-17
Piperidine derivatives having renin inhibiting activity
Grant 6,051,712 - Binggeli , et al. April 18, 2
2000-04-18
Sulfonamides
Grant 6,004,965 - Breu , et al. December 21, 1
1999-12-21
Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
Grant 5,962,682 - Breu , et al. October 5, 1
1999-10-05
Sulfonylaminopyrimidine carboxylic acid derivatives having endothelin inhibiting activity
Grant 5,856,484 - Breu , et al. January 5, 1
1999-01-05
Sulphonamides
Grant 5,837,708 - Breu , et al. November 17, 1
1998-11-17
Sulfonylaminopyrimidines
Grant 5,541,186 - Breu , et al. July 30, 1
1996-07-30
Phenylsulfonylamide pyrimidine
Grant 5,420,129 - Breu , et al. May 30, 1
1995-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed